Cargando…
An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1
BACKGROUND: Bcl-2-like members have been found to be inherently overexpressed in many types of haematologic malignancies. The small-molecule S1 is a BH3 mimetic and a triple inhibitor of Bcl-2, Mcl-1 and Bcl-XL. METHODS: The lethal dose 50 (LD(50)) values of S1 in five leukaemic cell lines and 41 ne...
Autores principales: | Zhang, Z, Liu, Y, Song, T, Xue, Z, Shen, X, Liang, F, Zhao, Y, Li, Z, Sheng, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658527/ https://www.ncbi.nlm.nih.gov/pubmed/23558901 http://dx.doi.org/10.1038/bjc.2013.152 |
Ejemplares similares
-
Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
por: Yoshimine, S, et al.
Publicado: (2013) -
Nicotine increases the resistance of lung cancer cells to cisplatin through enhancing Bcl-2 stability
por: Nishioka, T, et al.
Publicado: (2014) -
Bcl-2 expression predicts radiotherapy failure in laryngeal cancer
por: Nix, P, et al.
Publicado: (2005) -
Bcl-2 expression in rituximab refractory cutaneous B-cell lymphoma
por: Wobser, M, et al.
Publicado: (2007) -
Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma
por: Maruyama, R, et al.
Publicado: (2006)